iOx Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

iOx Therapeutics General Information

Description

Developer of therapeutics designed to stimulate the immune system to fight cancer. The company focuses on developing cancer immunotherapy which offers a series of compounds which stimulate an essential component of the immune system, natural killer T cells (NKT) for treatment of cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 5th Floor, Alder Castle
  • 10 Noble Street
  • London EC2V 7QJ
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

iOx Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 00.000 Completed Startup
4. Debt - General 10-Dec-2018 000 00.000 Completed Startup
3. Debt - General 08-Mar-2018 000 00.000 Completed Startup
2. Early Stage VC 09-Jul-2015 $2.86M $2.86M 00.000 Completed Startup
1. Grant Completed Startup
To view iOx Therapeutics’s complete valuation and funding history, request access »

iOx Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
To view iOx Therapeutics’s complete cap table history, request access »

iOx Therapeutics Board Members (4)

Name Representing Role Since
Anna Jenkins iOx Therapeutics Board Member 000 0000
Ian Walters iOx Therapeutics Board Member 000 0000
Jonathan Skipper iOx Therapeutics Board Member 000 0000
Vincenzo Cerundolo Ph.D iOx Therapeutics Founder & Board Member 000 0000
To view iOx Therapeutics’s complete board members history, request access »

iOx Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
Oxford Sciences Innovation Venture Capital Minority 000 0000 000000 0
Oxford Spin-out Equity Management Venture Capital Minority 000 0000 000000 0
To view iOx Therapeutics’s complete investors history, request access »